Irbesartan Blood Pressure Medication Lawsuit

If you or your loved one took the high blood pressure medication irbesartan (brand name: Avapro®) and were later diagnosed with cancer, you may be eligible to pursue compensation. Learn more about your legal options today.

Get a Free Case Review

Breaking News: FDA Recalls Irbesartan Blood Pressure Medication Due to Cancer Risk

In October 2021, Lupin Pharmaceuticals, Inc. voluntarily recalled all batches of high blood pressure medication irbesartan, as well as irbesartan and hydrochlorothiazide tablets (Avalide®) in the United States. The company found unsafe levels of the impurity N-nitrosoirbesartan, a probable human carcinogen, in certain batches.

Batches of these potentially dangerous medications were sold from October 2018 until January 2021, when the company discontinued the marketing of its irbesartan tablets, according to the U.S. Food and Drug Administration (FDA).

High Blood Pressure Medication Irbesartan Recall List 2021

All batches of the following medications and strengths have been recalled by Lupin Pharmaceuticals in the United States:

  • Irbesartan Tablets USP: 75 mg, 150 mg, and 300 mg
  • Irbesartan and Hydrochlorothiazide Tablets USP: 150 mg/12.5 mg and 300 mg/12.5 mg

If you took any of the high blood pressure drugs listed above and have since been diagnosed with cancer, you may be eligible to pursue compensation from an irbesartan recall lawsuit.

Irbesartan Side Effects

Though the FDA says that Lupin Pharmaceuticals does not appear to have received any reports of illness or side effects related to this issue, that’s not necessarily reassuring given the nature of the risk. According to studies, cancer can grow undetected for 10 years or more.

Because the medications in question were distributed between October 2018 and December 2020, even if someone developed cancer after taking irbesartan, they may not have displayed any symptoms yet.

Irbesartan Cancer Risk

Some batches of the blood pressure medication irbesartan, as well as irbesartan and hydrochlorothiazide, were found to contain unsafe levels of the impurity N-nitrosoirbesartan, which could cause cancer in humans. As a result, Lupin Pharmaceuticals issued a voluntary recall of these drugs on October 14, 2021.

The FDA advises patients who are currently taking irbesartan or irbesartan and hydrochlorothiazide to continue taking these medications, but to contact their physician or medical provider for advice regarding alternative treatment options.

If you or a loved one were diagnosed with cancer after taking irbesartan, contact us for a free consultation.

Get Help Filing an Irbesartan Recall Lawsuit

If you or your loved one took irbesartan or irbesartan and hydrochlorothiazide tablets and were later diagnosed with cancer, you may be able to file an irbesartan lawsuit — and Sokolove Law may be able to help.

As a national personal injury law firm, Sokolove Law has helped injured clients pursue justice and compensation from the companies that harmed them. Over the last 40+ years, we’ve recovered over $1.5 Billion on behalf of clients affected by dangerous drugs and medical devices.

Get a free case evaluation or call (800) 995-1212 today to learn more about your legal options. Our attorneys work on a contingency basis, so there are no out-of-pocket or upfront fees to work with us.

Irbesartan and Hydrochlorothiazide Tablets Recall FAQs

Which blood pressure medication is being recalled?

All batches and strengths of Lupin Pharmaceuticals’ high blood pressure medication irbesartan (brand name: Avapro), as well as irbesartan and hydrochlorothiazide tablets (Avalide), have been voluntarily recalled by the company. Certain batches may contain an unsafe level of the impurity N-nitrosoirbesartan, which is believed to cause cancer and other unhealthy side effects.

Why was irbesartan recalled?

The high blood pressure medication irbesartan and irbesartan and hydrochlorothiazide tablets were recalled by the drug company Lupin Pharmaceuticals, Inc. and the FDA after certain batches tested positive for an unacceptably high level of N-nitrosoirbesartan, a potentially carcinogenic impurity.

Is there a link between irbesartan and cancer?

Yes — certain batches of the high blood pressure medication irbesartan, as well as irbesartan and hydrochlorothiazide, were found to contain unsafe levels of the impurity N-nitrosoirbesartan, a probable carcinogen to humans. Get a free consultation today if you were diagnosed with cancer after taking irbesartan.

What company makes irbesartan?

Lupin Pharmaceuticals, Inc. produces irbesartan in the U.S., where it is sold under the brand name Avapro. Lupin Pharmaceuticals also produces irbesartan and hydrochlorothiazide tablets, which are sold under the brand name Avalide. In October 2021, Lupin Pharmaceuticals recalled both of these medications over a potential cancer risk.

Can you just stop taking irbesartan?

Though irbesartan has been recalled over a potential cancer-causing impurity, the FDA advises that patients who are taking irbesartan or irbesartan and hydrochlorothiazide tablets for high blood pressure speak with their physician or medical provider about alternative treatment options before they stop taking these medications.

If you or a loved one were diagnosed with cancer after taking irbesartan, contact us for a free case review to see if you are entitled to compensation.

Author:Sokolove Law Team
Sokolove Law Team

Contributing Authors

The Sokolove Law Content Team is made up of writers, editors, and journalists. We work with case managers and attorneys to keep site information up to date and accurate. Our site has a wealth of resources available for victims of wrongdoing and their families.

Last modified: November 16, 2021

View 2 Sources
  1. Hori, Sharon and Sanjiv Ghambir. Science Translational Medicine. “Mathematical Model Identifies Blood Biomarker–Based Early Cancer Detection Strategies and Limitations.” November 16, 2011. Retrieved from: https://www.science.org/doi/10.1126/scitranslmed.3003110. Accessed on October 25, 2021.
  2. U.S. Food & Drug Administration (FDA). "Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of All Irbesartan Tablets and Irbesartan and Hydrochlorothiazide Tablets Due to Potential Presence of N-nitrosoirbesartan Impurity." Retrieved from: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/lupin-pharmaceuticals-inc-issues-voluntarily-nationwide-recall-all-irbesartan-tablets-and-irbesartan#recall-announcement. Accessed on October 21, 2021.